What Abbott Laboratories's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 6 |
| Sells | 4 | 11 |
| Total trades | 10 | 61 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 61 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Conroy Kevin T | Director | Sep 23 | Withheld — tax / exercise cost · F | −52,507 | $103.99 | −$5.46M | 81,230 |
| Mccoy John A. | VICE PRESIDENT AND CONTROLLER | Sep 02 | Open-market sale · S | −27 | $109.54 | −$2.96K | 24,549 |
| Boudreau Philip P | EVP AND CFO | Sep 01 | Withheld — tax / exercise cost · F | −388 | $110.36 | −$42.8K | 70,784 |
| Mccoy John A. | VICE PRESIDENT AND CONTROLLER | Sep 01 | Withheld — tax / exercise cost · F | −52 | $110.36 | −$5.74K | 24,576 |
| Ford Robert B | CHAIRMAN AND CEO | Aug 25 | Open-market sale · S | −180,297 | $116.19 | −$20.9M | 306,461 |
| Ford Robert B | CHAIRMAN AND CEO | Aug 25 | Open-market sale · S | −218,535 | $115.57 | −$25.3M | 486,758 |
| Ford Robert B | CHAIRMAN AND CEO | Aug 25 | Exercise / conversion · M | +246,963 | $59.94 | +$14.8M | 705,293 |
| Ford Robert B | CHAIRMAN AND CEO | Aug 25 | Exercise / conversion · M | +151,869 | $44.40 | +$6.74M | 458,330 |
| Morrone Louis H. | EXECUTIVE VICE PRESIDENT | Aug 12 | Discretionary Transaction · I | −12 | $107.99 | −$1.3K | 0 |
| Morrone Louis H. | EXECUTIVE VICE PRESIDENT | Aug 11 | Open-market sale · S | −5,850 | $109.83 | −$643K | 70,724 |
| Morrone Louis H. | EXECUTIVE VICE PRESIDENT | Jun 30 | Withheld — tax / exercise cost · F | −269 | $92.71 | −$24.9K | 76,574 |
| Cushman Elizabeth C. | EVP, GC AND SECRETARY | Jun 27 | Withheld — tax / exercise cost · F | −560 | $94.12 | −$52.7K | 38,013 |
| Stratton John G | Director | May 07 | Open-market buy · P | +2,000 | $86.82 | +$174K | 23,319 |
| Moreland Mary K | EXECUTIVE VICE PRESIDENT | Apr 28 | Discretionary Transaction · I | +5,314 | $94.41 | +$502K | 17,159 |
| Starks Daniel J | Director | Apr 27 | Open-market buy · P | +10,000 | $92.65 | +$927K | 6,751,103 |
| Babineaux-Fontenot Claire | Director | Apr 24 | Grant / award · A | +2,286 | — | — | 7,603 |
| Blount Sally E. | Director | Apr 24 | Grant / award · A | +2,286 | — | — | 36,344 |
| McKinstry Nancy | Director | Apr 24 | Grant / award · A | +2,286 | — | — | 41,010 |
| Ahuja Nita | Director | Apr 24 | Grant / award · A | +2,286 | — | — | 2,286 |
| Gonzalez Patricia P. | Director | Apr 24 | Grant / award · A | +2,286 | — | — | 9,205 |
Loading...
